Despite its decision to scrap the drug, Pfizer on Monday said those studies met key goals and confirmed a certain form and dose of the pill with the potential to deliver "competitive efficacy and tolerability" in late-stage trials
[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C
These innovations address the strict regulatory and safety requirements of the medical device industry
Weaker bones can put more stress on joints, ligaments, and muscles
With combined activation (CagriSema) the effect does not add linearly, but supra-additively , which is why the combination has a stronger clinical result than either component alone
In respect to quantitative results, however, this promising approach has its inherent limitations